Brazil announces co-sponsorship of the WHA Resolution on Rare Diseases

We applaud Brazil for co-sponsoring the WHA Resolution on Rare Diseases alongside the Arab Republic of Egypt, Spain, Qatar, France, Malaysia, Chile, Panama, the Philippines, the State of Palestine, Kuwait, and Luxembourg.

As negotiations on the resolution are ongoing, now more than ever, we call on all Member States to support or co-sponsor the WHA Resolution and the Global Action Plan on Rare Diseases ahead of the WHO Executive Board meeting (3–11 February 2025).

The Global Action Plan is critical to ensuring sustainable solutions, greater equity for persons living with a rare disease and making Universal Health Coverage a reality.

Learn more about the Resolution
.

Luxembourg announces co-sponsorship of WHA resolution on rare diseases

We applaud Luxembourg for co-sponsoring the WHA Resolution on Rare Diseases alongside the Arab Republic of Egypt, Spain, Qatar, France, Malaysia, Chile, Panama, the Philippines, the State of Palestine, and Kuwait.

As negotiations on the resolution are ongoing, now more than ever, we call on all Member States to support or co-sponsor the WHA Resolution and the Global Action Plan on Rare Diseases ahead of the WHO Executive Board meeting (3–11 February 2025). Global action is necessary to ensure that rare diseases are recognized and prioritized in health systems worldwide.

Read more about the Resolution here.

RDI Launches Youth leadership programme

RDI is pleased to announce the launch of the RDI Youth Leadership Programme, an initiative designed to engage and empower young people within the rare disease community. This programme aims to ensure that the perspectives of young leaders are actively represented in global discussions and decision-making processes that shape the future of rare diseases.

Through this programme, participants will:

-Contribute their unique insights and expertise to the rare disease ecosystem

-Build essential leadership skills through capacity-building opportunities

-Foster collaboration across the global rare disease community

By empowering the next generation of advocates, the programme ensures that RDI aligns with the needs and expectations of the next generation and remains relevant in a rapidly evolving world.

Applications Now Open!

Deadline: January 31, 2025

Apply Here

Read the Terms of Reference

If you have any questions about the Programme or if are experiencing any difficulties with your application, please contact gaia.esposito@rarediseasesint.org

The state of palestine and Kuwait join egypt, spain, france, qatar, malaysia, panama, chile, and the philippines in co-sponsoring wha resolution

The State of Palestine and Kuwait have announced that they will co-sponsor the WHA Resolution on Rare Diseases at the WHA 2025 alongside Egypt, Qatar, Spain, Malaysia, France, Panama, Chile, and the Philippines.

Momentum continues to grow behind this initiative to improve the lives of Persons Living with a Rare Disease through global action. We applaud both the State of Palestine and Kuwait for affirming the need to make rare diseases a global health priority and ensure that no one is left behind.

Read the November 2024 Newsletter from Rare Diseases International

Not a subscriber yet? Sign up here

Join our Mailing List:

* indicates required

Read the October 2024 Newsletter from Rare Diseases International

Not a subscriber yet? Sign up here

Join our Mailing List:

* indicates required

RDI hosts side event at World Health Summit in Berlin

At the 2024 World Health Summit in Berlin, Rare Diseases International (RDI) hosted a side-event entitled “Why Prioritize Rare Diseases in Global Health Policy? Aligning with the World Health Assembly (WHA) Resolution on Rare Diseases”, on October 13th, 2024. Representatives from the Ministries of Health of Egypt, France, Spain, and Qatar participated alongside a diverse panel including 4 speakers with lived experience of rare diseases. The event was well attended with over 100 attendees over the course of the event, both in-person and on-line. You can read the event report here to see the event highlights. You can also watch the full event here. Amidst a very productive and insightful discussion, 3 principal takeaway messages emerged:

• A systems approach is needed: rare diseases must be integrated into health and financing systems as part of NCD and UHC frameworks. “Rare diseases should be driving UHC.” 

• It is critical to look at the wider social and economic impacts of rare diseases. “When we are talking about rare diseases we are not just talking about the patients, we are talking about their families, their classmates, their workmates.” 

• This is about political will: By co-sponsoring the resolution countries are putting rare diseases on the agenda at the highest level. “We know that implementation will be challenging but the rare diseases community has the expertise and we are ready more than ever.”

RDI is looking forward to continuing to support Egypt, Spain, Qatar, Malaysia, France, Panama, Chile, and more Member States to make the WHA Resolution on Rare Diseases a reality in 2025. You can find out more about the WHA Resolution initiative here.

Read the September 2024 Newsletter from Rare Diseases International

Not a subscriber yet? Sign up here

Join our Mailing List:

* indicates required

P4H and RDI announce collaboration to support innovation in health and social protection for Persons Living with a Rare Disease

Rare diseases affect more than just health: they are often a source of significant financial hardship. Individuals with rare diseases face high, often catastrophic, out-of-pocket costs for medical care. Together with travel expenses and lost income for both individuals living with a rare disease and their caregivers, these costs present a massive financial burden for many households.

 To ensure effective health coverage, increased access and adequate financial protection for all, we need innovative solutions. That is why the P4H Network and Rare Disease International (RDI) are partnering to enable global advocacy and collaboration to influence and support innovation in social health protection and health financing arrangements. The collaboration aims to investigate the scope, issues, needs, and existing approaches and to frame members’ interests and actions within a global perspective to promote best practices at all levels.

Through this partnership, P4H and RDI will contact P4H country focal persons and regional community facilitators, RDI member organizations, WHO experts, and OECD consultants and professionals to exchange information on national experiences in financing and social health protection of rare diseases. This information and preliminary data will be reviewed, validated and systematized through mapping exercises to develop a shortlist of countries with key sources for detailed information. Then, the rare disease situation in each country will be documented through questionnaires and structured interviews with primary sources.

By documenting the current financing and social health protection structure for rare diseases, existing challenges, and future plans for policy action in each country and region, P4H and RDI will investigate the impact of rare diseases on social health protection and health financing arrangements, along with financial hardship and household catastrophic health expenditure in line with the Sustainable Development Goals indicator 3.8.2 on catastrophic health spending. This data will serve as a valuable source in informing global and national policy initiatives related to Universal Health Coverage and rare diseases, providing opportunities to reduce financial hardship and enhance quality of life for Persons Living with Rare Diseases and their families around the world.